News
New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...
16hon MSN
A recent phase 2 clinical trial reveals that Ambroxol, a common cough medicine, shows promise in stabilizing psychiatric ...
People with Parkinson’s often stay silent about their diagnosis. Here’s what drives that silence and why understanding it ...
Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...
Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially ...
Scientists at the University of Sydney have uncovered a malfunctioning version of the SOD1 protein that clumps inside brain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results